PTX3 and posterior cortical atrophy: Our first study [13] also showed that PTX3 serum levels were significantly higher in patients with PCa (6.1 ± 4.9 vs. 2.4 ± 1.1 ng/mL; p = 0.001), thus, pointing at PTX3 as a potential serum PCa biomarker.